Claritin Tablet, Orally Disintegrating
Product Images NDC 11523-7202

2 FDA label images from Bayer Healthcare Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Claritin (NDC 11523-7202). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bayer Healthcare Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Back Carton Label (10 Count Outer Container Label Cropped 2)

Back Carton Label (10 Count Outer Container Label Cropped 2)
Drug Facts panel for Claritin Reditabs 5 mg orally disintegrating tablets containing loratadine. The label includes active ingredients, uses, warnings, directions, and other information for this over-the-counter antihistamine product by Bayer HealthCare LLC. Additionally, it shows instructions for tablet use from the blister pack.*
FDA Label Image

Front Label (10 Count Outer Container Label Cropped)

Front Label (10 Count Outer Container Label Cropped)
Packaging label for Claritin Reditabs 5 mg orally disintegrating tablets by Bayer HealthCare LLC. The label highlights non-drowsy Loratadine for indoor and outdoor allergies, with 10 tablets per package. It features a blue sky with clouds, green grass, and states the product provides 12-hour relief and melts in the mouth without water.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.